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Nowadays probably every person came across the term 
Psychotherapy. It seems, however, not 
to be so clear what psychotherapy 
actually means. Besides that, it 
seems to be not so clear, what a 
Psychotherapist does and how s/he 
can assist someone, who finds himself 
temporarily in distress. When we speak 
about psychotherapy, we refer to a form 
of therapeutic interaction or intervention 
which usually addresses emotional 
issues. 
Accredited psychotherapists 
are highly trained people, who have 
undergone strictly regulated schooling 
in one or more of the officially 
recognized forms of psychotherapy. 
This training takes up to four years 
and even more. During their training 
course psychotherapists have to 
undergo their own personal therapeutic 
journey. Following accreditation, a 
psychotherapist is asked to take 
part in supervision groups, personal 
development groups and to attend 
seminars and workshops to further 
his knowledge and education. The 
therapist’s on-going personal and 
professional journey will equip him 
for his métier with the right amount of 
empathy and experience to choose 
from the best instruments available the 
most appropriate one to work with the 
individual patient’s issues. 
Persons can avail themselves of 
the support of a psychotherapist as 
individual patients, groups, couples, 
or families. The session’s focus will 
address the person’s or the group’s 
environment, since human beings do 
not live isolated from one another. 
Fundamentally we all are historically 
- somewhat coarsely expressed – 
gregarious animals.
The journey of discovering the 
roots of the difficulties experienced 
throughout a momentary phase of life 
might bring into awareness issues with 
every day contacts like the partner, 
members of the patient’s close family, 
work, school, or any other social group. 
Confidentiality in psychotherapeutic 
sessions is of critical importance and 
stipulated in the regulatory statutes of 
the psychotherapeutic organization’s 
code of ethics. A psychotherapist who 
does not respect those statutes is in 
danger of losing his credibility, and also 
his right to practice in his profession. A 
trained professional would unlikely want 
to risk that. 
When it comes to the topics that 
can be dealt with in psychotherapy 
there is hardly anything that cannot be 
addressed. Psychotherapists however, 
might have specialized themselves in a 
particular field. In such a case, a patient 
can be referred to a colleague with the 
respective specialized background. 
Psychotherapy can improve the 
response to prescribed medication 
and help the patient to recover quicker. 
Vice-versa the psychotherapist might 
decide that it would be of advantage for 
the patient to see a medical practitioner 
to evaluate the possibility of introducing 
medication. The psychotherapist and 
the medical practitioner can thus 
decide together on the management 
of the patient by monitoring the 
improvement of the patient’s emotional 
rebalancing.
Psychotherapy aims to help patients 
to cope better with their lives and 
the challenges, learn about conflict 
management and self-growth, and to 
reach their full potential. Within the 
therapeutic setting, the psychotherapist 
creates an environment that is 
potentially healing for the patient. 
Mental and emotional health and fitness 
are efficient allies when it comes to 
seriously tackling all sorts of crisis. 
Therefore, the psychotherapist’s 
aspiration will be that of strengthening 
both, be it as prevention for future 
hardships, or as cure for a momentary 
deadlock in a difficult life-situation. 
 During eachsession the 
psychotherapist strives to increase 
awareness, insight and understanding. 
To reach this goal the therapist will 
use different techniques.  Amongst 
others the therapist will aim to support 
the patient to recognize his behaviour 
or thinking patterns that once might 
have been useful but now sabotages 
the patient’s well-being. Through 
broader awareness the patient can 
ultimately expand his capacity for self-
observation, become more aware to 
undesired behaviour, develop insight 
and empathy. 
Be it with medication or without, 
through the interventions given by the 
psychotherapist, the patient will with 
time be able to change his thoughts 
and feelings and as a result change his 
patterns and his behaviour. Through 
this changed behaviour the patient will 
increase his sense of well-being. 
Coming to the end of this 
therapeutic journey, the patient will be 
able to cope better with discomfort and 
distress, and his perception of reality 
will be balanced, so that he can clearly 
see the variety of his choices - and 
choose freely.  
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